Work

Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer

Year: 2018

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-018-5022-5

Authors: Sonia Vallet, Fengjuan Fan, Stefano Malvestiti, Martin Pecherstorfer, Martin Sattler, Andreas Schneeweiss, Henning Schulze-Bergkamen, Joseph T. Opferman, Michael H. Cardone, Dirk Jäger, Klaus Podar

Institutions: Heidelberg University, National Center for Tumor Diseases, Universitätsklinikum Krems, Karl Landsteiner University of Health Sciences, Wuhan Union Hospital, Huazhong University of Science and Technology, Harvard University, Dana-Farber Cancer Institute, St. Jude Children's Research Hospital, Eutropics Pharmaceuticals (United States), German Cancer Research Center

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2899465706

FWCI: 0.889

Cites: 50

Cited by: 19

Related to: 10